- Tytuł:
- A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma
- Autorzy:
- Źródło:
- Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 38(5):1421-1429
Czasopismo naukowe